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Summary
Background.— Randomized studies evaluating left atrial radiofrequency ablation (RFA) in
patients with persistent atrial ﬁbrillation undergoing mitral valve surgery are scarce and mono-
centric.
Abbreviations: AF, atrial ﬁbrillation; RFA, radiofrequency ablation; SAFIR, Surgery for atrial ﬁbrillation trial.
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Aim.— To evaluate the efﬁcacy of left atrial RFA concomitant with mitral valve surgery to
restore and maintain sinus rhythm.
Methods.— The SAFIR is a multicentre, double-blinded, centrally randomized study involv-
ing four university hospitals. Between December 2002 and September 2005, 43 patients with
mitral valve disease and long-standing, persistent atrial ﬁbrillation (duration > 6 months) were
included. We compared valvular surgery alone (n = 22) or with left atrial RFA (n = 21). The
main endpoint was sinus rhythm at 12 months without recurrence of arrhythmia during follow-
up. Secondary endpoints were surgical adverse events, atrial ﬁbrillation relapses, stroke and
echocardiographic measurements after three and 12 months’ follow-up. Analyses of the efﬁcacy
criteria were performed on an intention-to-treat basis.
Results.— The primary endpoint occurred signiﬁcantly more often in the RFA group than in
the control group (respectively, 12/21 patients [57%] vs 1/22 patients [4%]; p = 0.004). There
were more patients with sinus rhythm in the RFA group than in the control group at discharge
(72.7% vs 4.8%; p < 0.005), 3-month follow-up (85.7% vs 23.8%; p < 0.01) and 12-month follow-up
(95.2% vs 33.3%; p < 0.005). The patients in the RFA group had similar rates of postoperative
complications and stroke during follow-up as those in the control group.
Conclusions.— This multicentre study suggests that left atrial RFA is effective and safe in
patients with chronic atrial ﬁbrillation and mitral valve disease.
© 2009 Elsevier Masson SAS. All rights reserved.
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Résumé
Justiﬁcation.— Les études randomisées évaluant l’ablation de la ﬁbrillation atriale par appli-
cation de courant de radiofréquence au décours d’une chirurgie mitrale sont rares et
monocentriques.
Objectifs.— Évaluer l’efﬁcacité de l’ablation de la ﬁbrillation atriale compliquant une patholo-
gie valvulaire mitrale pour obtenir le retour et le maintien du rythme sinusal.
Méthodes.— L’étude Saﬁr est un essai multicentrique réalisé en double insu avec randomisation
centralisée impliquant quatre hôpitaux universitaires. Entre décembre 2002 et septembre 2005,
43 patients avec maladie valvulaire mitrale et ﬁbrillation atriale persistante (durée supérieure
à six mois) ont été inclus. Nous avons comparé la chirurgie valvulaire isolée (n = 22) à la chirurgie
vasculaire associée à un geste d’ablation de l’oreillette gauche (n = 21). Le critère de jugement
principal était la présence d’un rythme sinusal à 12mois sans récidive de l’arythmie pendant
le suivi. Les évènements indésirables postchirurgicaux, les rechutes de ﬁbrillation atriale, les
accidents vasculaires cérébraux et les mesures échocardiographiques à trois mois et 12mois
ont été colligés. L’analyse de l’efﬁcacité a été réalisée en intention de traiter.
Résultats.— Douze mois après l’intervention, 57 % des patients dans le groupe radiofréquence
étaient en rythme sinusal, (12/21) contre 4 % (1/22) dans le groupe témoin. Après 12mois de
suivi, la proportion de patients en rythme sinusal était signiﬁcativement plus élevée dans le
groupe radiofréquence que dans le groupe témoin 12/21 patients (57 % versus 1/22 patients, 4 % ;
p = 0,004). Il y avait, de fac¸on statistiquement signiﬁcative, plus de patients en rythme sinusal à
la sortie de l’hôpital dans le groupe radiofréquence par rapport au groupe témoin (72,7 % versus
4,8 % ; p < 0,005). La même différence en faveur du traitement par application de courant de
radiofréquence était observée à trois mois (85,7 % versus 23,8 % ; p < 0,001) et à 12mois de
suivi (95,2 % versus 33,3 % ; p < 0,005). Les patients du groupe traitement par radiofréquence
avaient des taux de complication postopératoire et d’accident vasculaire cérébral pendant le
suivi identique à ceux du groupe témoin.
Conclusion.— Cette étude multicentrique suggère que l’ablation de la ﬁbrillation atriale au
décours d’une chirurgie valvulaire mitrale est efﬁcace chez les patients avec ﬁbrillation atriale
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ackground
pproximately 50% of patients with mitral valve disease that
equires surgery present with AF [1—5]. Because over 70% of
hese patients continue to have arrhythmia after corrective
urgery [1,4], antiarrhythmic surgical treatments have been
eveloped. Since 1987, antiarrhythmic surgery for AF has
T
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ss droits réservés.
ssentially been based on a method of compartmentaliza-
ion of the left and right atria by a cut-and-sew procedure
alled ‘Maze’, which was developed by Cox et al. [6,7].
his reference technique is complex and requires more than
5minutes of extracorporeal circulation; consequently, it
as only been used successfully by a few highly specialized
urgical teams. The success of catheter ablation has paved
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outpatient basis. Validation of the endpoint criteria was car-
ried out by a critical-event validation panel made up of
three cardiologists who did not otherwise participate in the
study.Left atrial ablation and mitral surgery
the way for newer surgical approaches using simpler com-
partment surgery [8]. On the other hand, the antiarrhythmic
efﬁcacy of a Maze procedure with a less extensive muscle
cut has been suggested by Cox et al. [6]. Sueda et al. were
the ﬁrst to perform a left atrial lesion set for AF concomitant
to mitral valve surgery [9]. These investigators obtained an
AF-free rate of 78% at 12 months. The limited segmentation
pattern was based on mapping, which demonstrated shorter
cycle length in the left atria compared with the right atria.
One randomized study compared left versus biatrial cut-and-
sew techniques [10], but found no difference between the
two strategies, with an AF-free rate of 70% at one year in
the left atrial lesion set arm.
Deneke et al. [11] compared left versus biatrial RFA as an
antiarrhythmia intervention, and found no signiﬁcant differ-
ence between the two procedures. In two non-randomized,
single-centre studies [12,13], the success rate —deﬁned as
the persistence of sinus rhythm at one year— reached 70%
with the left atrial ablation only approach. With the same
lesion set, one randomized, single-centre study suggested
that sinus rhythm can be achieved at one year in 44% of
the patients treated with RFA [14]. In the era of evidence-
based medicine, there is a lack of multicentre studies for the
precise quantiﬁcation of the risk-beneﬁt ratio of left atrial
RFA associated with mitral valve surgery. In such a setting,
the fact that a cure for AF has not been proven to improve
the long-term prognosis [15] reinforces the need for a solid
validation methodology. Recently, a consensus statement on
surgical ablation of AF reminded us that ‘multicentre clini-
cal trials are needed to better deﬁne the relative safety and
efﬁcacy of various surgical tools and techniques’ [16]. The
aim of the SAFIR, a multicentre, double-blinded, centrally
randomized study, was to evaluate the efﬁcacy of left atrial
RFA concomitant with mitral valve surgery to promote sinus
rhythm.
Methods
Patient population
This trial was conducted according to French and European
Good Clinical Practices, and in keeping with the principles
of the Declaration of Helsinki in its current version, and
with French Law No. 88-1138 of 20 December 1988, mod-
iﬁed on 25 July 1994. This protocol was approved by the
Comité consultatif de protection des personnes se prêtant
à des recherches biomédicales Lyon A Committee on 17th
May 2001.
This double-blind, multicentre study was performed at
four university hospitals between August 2002 and Septem-
ber 2005. At each of the four centres, patients aged equal
or over 18 years who were admitted for mitral valve dis-
ease requiring surgery that was associated with persistent
AF evolving for more than six months were eligible. Patients
with left ventricular ejection fraction less than 35% and
left atrial transverse diameter greater than 60mm were
excluded. Immediate postoperative treatment and prescrip-
tion medication upon discharge were left to the discretion
of the physician in charge of the patient. Anticoagulant
treatment was maintained for at least three months after
surgery.
F
l771
urgical procedures
he RFA group included mitral valve surgery via the Water-
tone groove associated with isolation of the pulmonary
eins one by one or two by two. This procedure was
ompleted by an RFA line on the roof of the left auri-
le and a line joining the inferior borders of the right
r left inferior radiofrequency lesions to the mitral ring
n its posteromedian region (Fig. 1). Isolation of the left
ppendage was left to the discretion of the surgeon.
adiofrequency lesions were made with a temperature-
ontrolled 8 F/8mm catheter (EP Technologies, Boston
cientiﬁc Corp, San Jose, CA, USA), as described previously
17].
ollow-up
fter centralized randomization, all patients were followed
n parallel for 12 months, with three hospital consultations
at discharge, and again at three and 12 months). RFA was
onsidered successful if sinus rhythm was maintained at 12
onths with no symptomatic or documented episodes of AF
n repeated Holter monitoring during the entire follow-up
eriod. At the last follow-up visit, all the patients had Holter
onitoring. The secondary endpoints included the follow-
ng: adverse surgical events, stroke, AF recurrence (deﬁned
s a new episode of symptomatic AF or AF conﬁrmed by
lectrocardiogram), death by any cause and severe, undesir-
ble events other than death. Upon discharge, the physician
n charge of blinded follow-up examined the patient and
ollected data related to the endpoint criteria. Consul-
ations at three and 12 months were performed on anigure 1. Location of the left atrial lesion sets. Isolation of the
eft appendage was left to the discretion of the surgeon.
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tatistical analysis
ccording to the data in the literature when the study was
esigned [1,4], approximately 70% of patients with AF of
alvular origin for more than one year keep this arrhythmia
fter isolated valve replacement versus only 20% of cases
ith associated antiarrhythmic surgery [1,4]. With an alpha
isk set at 5% and a beta risk at 10%, the number of patients
equired was estimated to be at least 23 patients per group.
o account for patients lost to follow-up, an enrolment of
0 patients per group was considered sufﬁcient. Enrolment
as slower than anticipated and was therefore extended
o two years, but ceased in September 2005 due to lack of
unding.
Analyses of the efﬁcacy criteria were performed on an
ntention-to-treat basis. Continuous data are expressed as
ean± standard deviation. All statistical tests were bilat-
ral with a signiﬁcance threshold of 0.05. Group comparisons
2ere performed with the Chi test or Fisher’s exact test and
tudent’s t-test.
The authors had full access to the data and take respon-
ibility for its integrity. All authors have read and agree to
he manuscript as written.
A
s
c
r
Table 1 Demographic, clinical and echocardiographic data.
Valve surgery alo
Age (years) 66.31± 9.7
Men 11 (50.0)
Weight (kg) 73.6± 14.2
Height (cm) 167.5± 10.7
Mean atrial ﬁbrillation duration (months) 89.2
Mitral regurgitation 14 (63.6)
Mitral stenosis 5 (22.7)
History of atrial ﬂutter 2 (9.1)
Previous myocardial infarction 2 (10)
History of stroke 2 (13)
Hypertension 6 (50)
Heart failure [16] (75.0)
LVEF (%) 61.3± 9.45
LVEDD (mm) 54.3± 8.3
Left ventricular hypertrophy 19 (86.4)
Left atrial diameter (mm) 52.6± 11
Values are number (%) or mean± standard deviation. Not all patients w
LVEDD: left ventricular end diastolic diameter; LVEF: left ventricular e
Table 2 Surgical data.
Valve surgery alone (n = 22
Mitral valve repair 13 (59.9)
Mitral valve replacement 17 (80.9)
Tricuspid annuloplasty 6 (27.3)
Aortic valve replacement 3 (13.6)
Aortic clamp time (min) 74± 19
Mean hospital stay (days) 16
Values are number (%) or mean± standard deviation.P. Chevalier et al.
esults
tudy population
orty-three patients from four centres were randomized:
1 to the RFA group and 22 to the control group. Demo-
raphic data are shown in Table 1. Only weight and height
ere signiﬁcantly lower in the RFA group. Surgical data are
resented in Table 2. The proportion of patients treated for
itral valve replacement was higher in the control group
han in the RFA group (80.9% vs 45.4%, respectively; p = 0.03
0.03]). The mean aortic cross-clamp duration was simi-
ar in the RFA group and in the control group (74± 21min
s 93± 32min [74min vs 93min, respectively]). The mean
uration of initial hospitalization was similar in both groups
16 days).
ollow-upfter one year of follow-up, the primary endpoint occurred
igniﬁcantly more frequently in the RFA group than in the
ontrol group (12/21 patients [57%] vs 1/22 patients [4%],
espectively; p = 0.004). This difference favouring RFA was
ne (n = 22) Radiofrequency ablation (n = 21) p
69.1± 6.2 0.27
5 (23.8) 0.14
62.4± 9.8 0.005
161.7± 7.7 0.05
161 0.12
12 (57.1) 0.75
4 (19.1) 1
3 (14.3) 0.66
3 (13 []) 1
0 (0) 0.22
8 (66) 0.4
[13] (63.6) 1
59.8± 8.5 0.59
51.86± 7.89 0.35
18 (85.7) 1
54.63± 10.9 0.58
ere assessed for each categorical characteristic.
jection fraction.
) Radiofrequency ablation (n = 21) p
4 (19) 0.01
10 (45.5) 0.03
1 (4.8) 0.1
3 (14.2) 1
93± 32 0.4
16 0.5
Left atrial ablation and mitral surgery 773
Table 3 Sinus rhythm at each consultation.
Valve surgery alone (n = 22) Radiofrequency ablation (n = 21) p
Discharge 1 (4.76) 16 (72.73) 0.005
At 3 months 5 (23.81) 18 (85.71) 0.0126
At 12 months 7 (33.33) 20 (95.24) 0.005
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also present after three and 12 months (Table 3). At 12
months, the numbers of class I, II and III antiarrhythmic pre-
scriptions were similar in the two groups (control vs RFA: 1
vs 2, 11 vs 7 and 6 vs 7, respectively). Eighteen patients in
the control group were treated with diuretics versus 13 in
the RFA group (p = 0.14). Twenty-one patients in the control
group were treated with vitamin K antagonists versus 13 in
the RFA group. Thirteen of 43 (30%) patients underwent elec-
tric cardioversion during follow-up (11 in the control group
and two in the RFA group). No patient was lost to follow-up.
Clinical events
There were 39 validated intercurrent events in 22 patients.
Without reaching the signiﬁcance threshold, the propor-
tion of patients presenting with at least one undesirable
event was higher in the control group than in the RFA
group (11/22 [50%] patients vs 16/21 [76%] patients, respec-
tively; p = 0.14). There was one death in the RFA group.
This patient, who had undergone tricuspid and mitral
valve replacement, presented with postoperative cardio-
genic shock rapidly followed by massive ischaemic stroke. It
was necessary to implant pacemakers in ﬁve patients (three
patients in the RFA group and two patients in the control
group). One patient from each group underwent a second
valve replacement. Four patients presented with severe
postoperative haemorrhaging: one patient in the RFA group
(haematoma of the psoas) and three patients in the con-
trol group (mediastinal bleeding and haemothorax). Three
patients in the RFA group had strokes. One patient has post-
operative left hemiplegia due to gas embolism. Another
patient was readmitted seven months postoperatively after
a cerebrovascular accident in the context of a prosthetic
thrombosis. A second mitral valve replacement was per-
formed. During the immediate postoperative period, one
patient suffered a comitial crisis with hemiplegia that was
resolved in less than six hours. In the control group, only
one patient presented with a transitory cerebral ischaemic
accident. One patient in each group had atrial tachycardia.
Echocardiographic data
The size of the left atria at three months was signif-
icantly smaller in the RFA group than in the control
group (45.90± 7.46mm vs 52.71± 7.12mm, respectively;
p = 0.01). Although this difference persisted at 12 months,
it was no longer signiﬁcant. At the end of the trial, all 12
patients with sinus rhythm in the RFA group had an A-wave
with a mean velocity of 69± 30mm/s. The A-wave veloc-
ity was signiﬁcantly lower in nine patients in the RFA group
than in 12 patients in the control group at three months
p
2
w
[
o0.73± 0.42 vs 1.67± 0.25 cm/s, respectively; p = 0.005) and
2 months (0.69± 0.30 vs 1.04± 0.25 cm/s, respectively;
= 0.04). The left ventricular ejection fraction and left ven-
ricular end-diastolic diameter measured at discharge, three
onths and 12 months were similar in the two groups, with a
endency toward reduction of the left ventricular end dias-
olic diameter in the RFA group compared with the control
roup (48.67± 4.23mm vs 51.19± 7.30mm, respectively;
= 0.22).
iscussion
o our knowledge, this study is the ﬁrst multicentre trial to
onﬁrm the efﬁcacy of left atrial RFA associated with mitral
alve surgery to maintain sinus rhythm one year postoper-
tively. However, because of the absence of difference in
he stroke rate between the two groups, the study does not
upport any beneﬁt of the ablation procedure. The overall
omplication rate, vascular cerebral event rate and dura-
ion of initial hospitalization did not differ in patients who
eceived RFA compared with the control group, although the
uration of extracorporeal circulation was higher in the RFA
roup than in the control group.
The SAFIR trial had three methodological advantages
ompared with studies published previously: it had a multi-
entre design, a centralized randomization procedure, and
alidated endpoint criteria and adverse events as deter-
ined by an independent panel of experts. The number
f patients included was close to the number required per
he protocol (23 evaluable patients per group in the ﬁnal
nalysis). No patient was lost to follow-up. The indepen-
ent funding and a complete report of adverse events also
epresent the study’s strengths.
revious studies
ew studies have evaluated endocardial left atrial RFA
oncomitant to valve surgery [12—14,18]. The two previ-
us randomized trials had methodological ﬂaws that limited
heir interpretation [14,18]. What RFA lesions have in com-
on in all studies is complete isolation of all the pulmonary
esions associated with at least one line drawn towards the
itral valve annulus. Deneke et al. [18] compared the out-
omes of 15 patients who had a combined procedure with 15
atients who had valve surgery alone. At 12 months, 81.8% of
atients with left-sided ablation were in sinus rhythm versus
1.4% in the surgery-alone group. In a study of 101 patients
ith mitral valve disease and permanent AF, Doukas et al.
14] reported that sinus rhythm was present after one year
f follow-up in 44.4% of the patients in the mini-Maze group
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[74
ersus 4.5% of the 44 patients in the control group. This pre-
ious study, like the SAFIR study, had a lower success rate
han that of non-randomized investigations. Interestingly,
he average efﬁcacy of 50% correlates with the left atrial
atheter ablation in patients with heart failure and chronic
F [19]. By comparison, Cox-Maze III RFA has been eval-
ated in one randomized study involving 70 patients with
ermanent AF [20]. The efﬁcacy of this extensive ablation
esion set that yields a 79% freedom from arrhythmias is in
ccord with the critical mass hypothesis [21]. The debate
ver whether or not the left atrial appendage should be
ncluded in the lesion set is neither fuelled nor enlightened
y the SAFIR study.Adverse event proﬁle
An important issue is related to the risk—beneﬁt equation
f an additional ablation procedure in mitral valve patients.
lthough the adverse event rates were particularly high in
he SAFIR study, they did not differ between groups. Other
tudies are in agreement with these results, strengthened by
he fact that the duration of hospitalization was the same
n the two groups with and without RFA [14]. With left atrial
blation surgery, complications such as excessive bleeding
r abnormal heart rhythm requiring pacemaker implantation
lso appear to be less frequent than those observed with the
i-atrial Cox-Maze procedure [11].
trial transport function
he quality of left atrial mechanical function is essential to
educe the risk of thromboembolic stroke. In the SAFIR trial,
he antiarrhythmic RFA intervention was associated with a
eduction in the size of the left atrium compared with that
n the control group. This difference was maintained at 12
onths, but was not signiﬁcant. Interestingly, atrial contrac-
ility was lower in the control group than in the mini-Maze
roup. Decreased contractility has also been documented
fter left atrial circumferential catheter ablation [22]. The
act that muscle cut may lead to abnormal left atrial velocity
as also strengthened with a surgical approach by Lonner-
olm et al. [23]. Precise quantiﬁcation with new imaging
echniques for atrial transport function is needed to pro-
ide information on the necessity for anticoagulant therapy
n patients in sinus rhythm after surgical ablation of AF.
tudy limitations
he absence of detection of asymptomatic paroxystic AF is
he main limitation of this study. However, AF recurrence in
he patient population studied in this trial occurs preferen-
ially in the persistent rather than in the paroxystic mode.
oreover, the restrictive character of the principal endpoint
dopted in the SAFIR trial (sinus rhythm at each evaluation
nd an absence of symptomatic AF between consultations)
onsolidates the efﬁcacy results observed. The proportion
f patients with mitral valve replacement was signiﬁcantly
igher in the control group than in the RFA group. However,
ecause the type of mitral surgery has not been described as
prognostic factor for the recurrence of AF, it is unlikely that
his characteristic inﬂuenced our results. Finally, the impact
f coronary disease on the ablation procedure as suggested
y Melo et al. [24] was not evaluated owing to the size and
he design of the study, which precluded ﬁrm conclusions
eing made regarding changes attributed to this condition.
[P. Chevalier et al.
onclusions
he results of this multicentre study conﬁrm that RFA limited
o the left atrium during mitral surgery increases the chance
f maintaining sinus rhythm at one year. Importantly, the
FA procedure was not associated with increased morbidity.
he SAFIR study results suggest that improved ablation pro-
edures should make it possible to obtain better electrical
tability results.
ources of funding
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romoted by the hospices civils de Lyon.
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